<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To examine the impact of <z:mp ids='MP_0002055'>diabetes</z:mp> duration, <z:hpo ids='HP_0006280'>chronic pancreatitis</z:hpo> and other factors on <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> risk </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: This retrospective cohort study using the UK General Practice Research Database compared <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> incidence and risk in patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2DM) versus patients without <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Multivariate Cox regression adjusting for age, sex, history of <z:hpo ids='HP_0006280'>chronic pancreatitis</z:hpo>, <z:e sem="disease" ids="C0016977" disease_type="Disease or Syndrome" abbrv="">gallbladder disease</z:e>, <z:hpo ids='HP_0001513'>obesity</z:hpo>, smoking and alcohol use and Charlson comorbidity index was used to estimate hazard ratio (HR) [95% confidence interval, CI] </plain></SENT>
<SENT sid="3" pm="."><plain>Analyses were repeated using various time windows for <z:mp ids='MP_0002055'>diabetes</z:mp> duration </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A total of 1903 incident <z:hpo ids='HP_0002894'>pancreatic cancers</z:hpo> were identified, 436 in patients with T2DM (78.76 per 100 000 person-years [95% CI: 71.54, 86.51]) and 1467 in patients without <z:mp ids='MP_0002055'>diabetes</z:mp> (11.46 per 100 000 person-years [10.88, 12.06]) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0002894'>Pancreatic cancer</z:hpo> risk was significant for T2DM (adjusted HR 1.80 [1.52, 2.14]), increasing age, history of <z:hpo ids='HP_0006280'>chronic pancreatitis</z:hpo> and tobacco use </plain></SENT>
<SENT sid="6" pm="."><plain>For patients with <z:hpo ids='HP_0006280'>chronic pancreatitis</z:hpo> and T2DM, the adjusted HR was 12.12 [6.02, 24.40] </plain></SENT>
<SENT sid="7" pm="."><plain>Incidence was highest in patients with ≥5 year duration of T2DM </plain></SENT>
<SENT sid="8" pm="."><plain>In patient populations with duration of T2DM ranging from ≥1 to ≥5 years, adjusted HRs remained significant but point estimates attenuated slightly with longer duration of T2DM </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Patients with T2DM had an 80% increased risk of <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> versus patients without <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Patients with T2DM and <z:hpo ids='HP_0006280'>chronic pancreatitis</z:hpo> were 12 times more likely to develop <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> </plain></SENT>
</text></document>